Epstein & White Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,059
Closed -$248K 87
2020
Q3
$248K Sell
3,059
-639
-17% -$50.1K 0.09% 61
2020
Q2
$276K Sell
3,698
-2,003
-35% -$151K 0.1% 51
2020
Q1
$419K Buy
+5,701
New +$448K 0.18% 41
2019
Q4
Sell
-9,193
Closed -$741K 81
2019
Q3
$741K Buy
9,193
+420
+5% +$33.7K 0.36% 31
2019
Q2
$672K Buy
8,773
+3,750
+75% +$287K 0.36% 31
2019
Q1
$395K Buy
+5,023
New +$376K 0.23% 47
2018
Q2
Sell
-6,438
Closed -$325K 112
2018
Q1
$325K Sell
6,438
-49
-0.8% -$2.65K 0.21% 77
2017
Q4
$348K Buy
+6,487
New +$360K 0.2% 70

Other funds holding MRK

Epstein & White Financial's MRK Position: Q4 2020 in Review

Epstein & White Financial sold out of Merck (MRK) in Q4 2020, closing a stake of 3,059 shares — an estimated $248K sold.

Epstein & White Financial first reported a position in MRK in Q4 2017 and held it in 8 quarters. The position peaked at $741K in Q3 2019. 2,708 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • Epstein & White Financial reported no remaining Merck position as of Q4 2020 after selling out during the quarter.
  • Epstein & White Financial sold 3,059 Merck shares in Q4 2020, an estimated $248K.
  • Epstein & White Financial first reported a position in Merck in Q4 2017 and held it in 8 quarters.
  • Epstein & White Financial's Merck position peaked at $741K in Q3 2019.
  • 2,708 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Epstein & White Financial's 13F filing for Q4 2020, filed 25 Jan 2021.